Market Overview - U.S. stocks experienced an upward trend, with the Dow Jones index increasing by over 300 points, closing at 45,109.99, a rise of 0.72%. The NASDAQ rose by 0.37% to 21,177.85, and the S&P 500 gained 0.53% to 6,404.23 [1] - European shares also saw gains, with the eurozone's STOXX 600 up by 0.4%, Spain's IBEX 35 Index rising by 0.5%, London's FTSE 100 increasing by 0.3%, Germany's DAX 40 gaining 0.1%, and France's CAC 40 up by 0.3% [5] - Asian markets closed mixed, with Japan's Nikkei 225 up by 0.05%, Hong Kong's Hang Seng gaining 0.93%, China's Shanghai Composite increasing by 1.45%, while India's BSE Sensex fell by 0.85% [6] Company Performance - BJ's Wholesale Club Holdings, Inc. saw its shares drop by approximately 7% after reporting second-quarter revenue that missed expectations. The company reported adjusted earnings per share of $1.14, surpassing the analyst consensus estimate of $1.09, but quarterly sales of $5.38 billion, a 3.4% year-over-year increase, fell short of the expected $5.48 billion [2] - EpicQuest Education Group International Ltd experienced a significant share price increase of 176% to $1.50 following a year-over-year increase in H1 financial results [9] - ModivCare Inc shares surged by 60% to $0.90 after announcing a Chapter 11 bankruptcy filing along with a $100 million investment commitment from secured lenders [9] - PMGC Holdings Inc shares rose by 66% to $3.14 [9] - Aptorum Group Ltd shares dropped by 39% to $2.60 after a previous rally of 234.65% [9] - 180 Life Sciences Corp shares fell by 35% to $3.14 after an 8% decline the previous day [9] - 5E Advanced Materials Inc shares decreased by 23% to $3.55 following the announcement of an $8.31 million public offering [9] Commodity Market - In commodity trading, oil prices increased by 0.4% to $63.74, while gold prices decreased by 0.2% to $3,376.20. Silver prices fell by 0.3% to $37.970, and copper prices rose by 0.1% to $4.4480 [4]

U.S. stocks traded lower midway through trading, with the Dow Jones index falling around 50 points on Thursday.The Dow traded down 0.62% to 44,660.91 while the NASDAQ fell 0.74% to 21,016.48. The S&P 500 also fell, dropping, 0.66% to 6,353.29.Check This Out: How To Earn $500 A Month From Intuit Stock Ahead Of Q4 EarningsLeading and Lagging SectorsHealth care shares jumped by 0.7% on Thursday.In trading on Thursday, consumer staples stocks fell by 0.9%.Top HeadlineShares of Walmart Inc. WMT fell 4% on Thursd ...

Company Performance - Dollar General Corporation reported first-quarter earnings that exceeded expectations, with net sales increasing by 5.3% to $10.44 billion, slightly below the consensus of $10.64 billion [2] - The company achieved a net income of $391.9 million, up 7.9%, with earnings per share of $1.78, surpassing the consensus estimate of $1.58 [2] - Dollar General updated its fiscal year 2025 sales growth expectations to approximately 3.7% to 4.7%, an increase from the previous forecast of 3.4% to 4.4% [3] - The earnings guidance was revised from $5.10-$5.80 per share to $5.20-$5.80, compared to the consensus of $5.62 [3] Market Trends - Information technology shares increased by 0.6% on Tuesday, indicating a positive trend in the sector [1] - Real estate stocks experienced a decline of 1.1%, reflecting challenges in that sector [1] - In commodity markets, oil prices rose by 1% to $63.10, while gold prices fell by 0.9% to $3,367.80 [5] Global Market Overview - European shares showed mixed results, with the eurozone's STOXX 600 declining by 0.1% and Spain's IBEX 35 Index falling by 0.7%, while London's FTSE 100 rose by 0.1% [6] - Asian markets closed mixed, with Japan's Nikkei down by 0.06% and Hong Kong's Hang Seng Index up by 1.53% [9]

Core Viewpoint - LifeMD, Inc. reported quarterly earnings of $0.01 per share, exceeding the Zacks Consensus Estimate of a loss of $0.04 per share, marking a significant improvement from a loss of $0.19 per share a year ago, resulting in an earnings surprise of 125% [1] Financial Performance - LifeMD posted revenues of $65.7 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 5.20%, compared to revenues of $44.14 million in the same quarter last year [2] - Over the last four quarters, the company has exceeded consensus EPS estimates two times and topped consensus revenue estimates three times [2] Stock Performance - LifeMD shares have increased approximately 52.3% since the beginning of the year, contrasting with the S&P 500's decline of -3.9% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.02 on revenues of $64.9 million, and for the current fiscal year, it is $0.06 on revenues of $267.95 million [7] Industry Outlook - The Medical Services industry, to which LifeMD belongs, is currently ranked in the top 25% of over 250 Zacks industries, indicating a favorable outlook [8]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased ModivCare Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - The Class Period for the ModivCare securities is from November 3, 2022, to September 15, 2024 [1]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [2][5]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions [3]. - Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company at the time [3]. - The firm has consistently ranked highly in securities class action settlements, recovering hundreds of millions of dollars for investors [3]. Group 3: Case Allegations - The lawsuit alleges that ModivCare's defendants made materially false and misleading statements and failed to disclose adverse facts about the company's business and operations [4]. - Specific issues cited include the deterioration of free cash flow in ModivCare's non-emergency medical transportation segment, which negatively impacted adjusted EBITDA and liquidity [4]. - The lawsuit claims that when the true details were revealed, investors suffered damages due to the misleading statements [4].

NEW YORK, March 27, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in ModivCare Inc. ("ModivCare" or the "Company") (NASDAQ: MODV) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ModivCare investors who were adversely affected by alleged securities fraud between November 3, 2022 and September 15, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/modivcare-inc-lawsui ...

Core Viewpoint - ModivCare Inc. is facing a class action lawsuit due to allegations of false statements and concealment of information that negatively impacted the company's financial performance, particularly in its Non-Emergency Medical Transportation (NEMT) segment [3]. Group 1: Allegations and Financial Impact - The lawsuit claims that certain contracts in ModivCare's NEMT segment led to a deterioration in the company's free cash flow [3]. - It is alleged that contract renegotiations and pricing accommodations adversely affected the company's adjusted EBITDA [3]. - The company reportedly faced liquidity issues as a result of these factors, and the defendants' positive statements about the company's business were misleading [3]. Group 2: Class Action Details - The class period for the lawsuit is defined as November 3, 2022, to September 15, 2024 [3]. - Shareholders who purchased shares during this period are encouraged to register for participation in the class action, with a deadline set for March 31, 2025 [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure that companies engage in responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Core Viewpoint - ModivCare Inc. is facing allegations of making false statements and concealing information that negatively impacted its financial performance, particularly in its Non-Emergency Medical Transportation (NEMT) segment [1][2]. Group 1: Allegations and Financial Impact - The complaint alleges that certain contracts in ModivCare's NEMT segment caused a deterioration in the company's free cash flow [1]. - As a result of these issues, the company experienced negative impacts on its adjusted EBITDA due to contract renegotiations and pricing accommodations [1]. - The company was reported to have insufficient liquidity, and the defendants' positive statements regarding the company's business and prospects were deemed materially misleading [1]. Group 2: Class Action Details - The class period for the allegations is from November 3, 2022, to September 15, 2024 [1]. - Shareholders who purchased shares during this period are encouraged to register for the class action, with a deadline set for March 31, 2025 [2]. - Participants will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [2].

NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in ModivCare Inc. ("ModivCare" or the "Company") (NASDAQ: MODV) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ModivCare investors who were adversely affected by alleged securities fraud between November 3, 2022 and September 15, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/modivcare-inc-lawsui ...

Core Viewpoint - A class action securities lawsuit has been filed against ModivCare Inc. for alleged securities fraud affecting investors between November 3, 2022, and September 15, 2024 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that ModivCare made false statements and concealed information regarding contracts in its Non-Emergency Medical Transportation (NEMT) segment, which led to a deterioration in free cash flow [2]. - Allegations include that contract renegotiations and pricing accommodations negatively impacted the Company's adjusted EBITDA, and that the Company faced liquidity issues [2]. - The defendants' positive statements about ModivCare's business operations and prospects were deemed materially misleading and lacked a reasonable basis [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until March 31, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4].